Solid Therapeutics ApS: Financial statements 2024
CVR: 43007068
Source: annual report 2024, Danish Business Authority
01/01/2024 – 31/12/2024
Solid Therapeutics ApS (CVR 43007068) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK -4,213,656 and a net result of DKK -6,758,207 compared with DKK -3,483,115 the year before. Equity in the 2024 report amounted to DKK -10,998,141. The company had 4 employees in the financial year.
- Gross Profit
- DKK -4,213,656
- Profit/Loss
- DKK -6,758,207
- Equity
- DKK -10,998,141
- Total Assets
- DKK 11,003,832
- Employees
- 4
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2024 | - | -4.2 mio. | -6.8 mio. | -11 mio. | 4 |
| 2023 | - | -2.7 mio. | -3.5 mio. | -4.2 mio. | 2 |
| 2022 | - | -398 t. | -797 t. | -757 t. | 1 |
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2024
Solid Therapeutics ApS has published its annual report for 2023. Gross profit came to DKK -2,738,806, and the net result was DKK -3,483,115.
About Solid Therapeutics ApS
Solid Therapeutics ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2022. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of John Sørensen Haurum. The company's owners include John Sørensen Haurum, Stine Helene Falsig Petersen and Anne Mette Hyldgaard Trauelsen. In 2025, the company reported a gross profit of DKK -1,687,751 and a net result of DKK -4,355,625 compared with DKK -6,758,207 the year before. Equity in the 2025 report amounted to DKK -15,353,766.